Here, we demonstrated that administration of ACVR2B/Fc was able to preserve body weight, fat, cancellous bone, skeletal muscle mass, and skeletal muscle strength in hosts bearing metastatic human HCT116 CRC. Here, ACVR2B is linked to colorectal carcinoma.